Page last updated: 2024-11-03

propafenone and Glaucoma

propafenone has been researched along with Glaucoma in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patane', S1
Marte, F1
Di Bella, G1
Pugliatti, P1

Other Studies

1 other study available for propafenone and Glaucoma

ArticleYear
Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    International journal of cardiology, 2008, Jun-06, Volume: 126, Issue:3

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; C

2008